small molecule

VELTIN

CLINDAMYCIN PHOSPHATE; TRETINOIN

Loss of exclusivity—loss of exclusivity

CompanyAlmirall →See this company's full patent-cliff portfolio

Drug detail

Brand name	VELTIN
Active ingredient	CLINDAMYCIN PHOSPHATE; TRETINOIN
Strength	1.2%;0.025%
Dosage form	GEL
Route	TOPICAL
Modality	Small molecule
FDA approval	July 2010
Marketing status	RX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.